University of Ottawa

- Country
- šØš¦Canada
- Ownership
- Private
- Established
- 1848-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.uottawa.ca
Clinical Trials
107
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (102 trials with phase data)⢠Click on a phase to view related trials
The Impact of Wearing the Hijab on Whole-body Heat Loss During Exercise-heat Stress
- Conditions
- Heat StressTemperature Change, Body
- First Posted Date
- 2025-09-15
- Last Posted Date
- 2025-09-15
- Lead Sponsor
- University of Ottawa
- Target Recruit Count
- 12
- Registration Number
- NCT07174180
- Locations
- šØš¦
University of Ottawa, Ottawa, Ontario, Canada
Managing Impact-related Leakage During Exercise Using Intravaginal Support
- Conditions
- Stress Urinary Incontinence (SUI)
- First Posted Date
- 2025-08-05
- Last Posted Date
- 2025-08-05
- Lead Sponsor
- University of Ottawa
- Target Recruit Count
- 30
- Registration Number
- NCT07103161
- Locations
- šØš¦
University of Ottawa, Faculty of Health Sciences building, 200 Lees Avenue, Ottawa, Ontario, Canada
Improving Patient Mental Health With Psychotherapist Virtual Training
- Conditions
- Mental Disorders
- First Posted Date
- 2025-07-28
- Last Posted Date
- 2025-07-28
- Lead Sponsor
- University of Ottawa
- Target Recruit Count
- 489
- Registration Number
- NCT07087730
- Locations
- šØš¦
University of Ottawa, Ottawa, Ontario, Canada
Identifying the Limits of Survivability in Heat-exposed Older Females
- Conditions
- Heat StressAgingTemperature Change, BodyThermoregulationHeat Exposure
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-08-17
- Lead Sponsor
- University of Ottawa
- Target Recruit Count
- 12
- Registration Number
- NCT07032493
- Locations
- šØš¦
University of Ottawa, Ottawa, Ontario, Canada
Social Prescribing for Advancing Resilience in Kids: A Pilot Study of Social Prescribing
- Conditions
- Youth Mental Health and WellbeingFeasibility and Acceptability of the Social Prescribing Program
- First Posted Date
- 2025-06-15
- Last Posted Date
- 2025-06-15
- Lead Sponsor
- University of Ottawa
- Target Recruit Count
- 170
- Registration Number
- NCT07022561
- Locations
- šØš¦
University of Ottawa, Ottawa, Ontario, Canada
- Prev
- 1
- 2
- 3
- 4
- 5
- 22
- Next
News
Heavy Cannabis Use Linked to Triple Mortality Risk and Rising Psychosis Cases, Studies Find
People diagnosed with cannabis use disorder (CUD) face nearly triple the risk of death over five years compared to the general population, with a tenfold increase in suicide risk, according to a large Canadian study.
ER Visits for Psychedelics Linked to Higher Mortality and Schizophrenia Risk, Studies Find
Emergency room patients treated for psychedelic use face a 2.6-fold higher risk of death within five years compared to the general population, with particularly elevated risks for suicide, cancer, and overdose.
Hypovolemic Phlebotomy Reduces Transfusion Needs in Liver Surgery
A clinical trial demonstrates that removing approximately 10% of a patient's blood before liver surgery significantly reduces the need for blood transfusions during the procedure.
Aerobic Exercise During Chemotherapy May Improve Cognitive Function in Breast Cancer Patients
⢠Women undergoing chemotherapy for breast cancer reported improved cognitive function when participating in an aerobic exercise program, according to the ACTIVATE trial. ⢠The study found that patients who started aerobic exercise alongside chemotherapy experienced better self-reported mental abilities compared to those receiving standard care alone. ⢠Objective neuropsychological testing showed similar cognitive performance between the exercise and standard care groups, but exercise still improved quality of life. ⢠Researchers suggest integrating exercise assessment and referral into routine cancer care to support both physical and mental health during and after treatment.
Edaravone Shows Promise in Targeting Glioblastoma Stem Cells
A recent study indicates that edaravone, an existing ALS drug, can be repurposed to target brain tumor stem cells (BTSCs) in glioblastoma.